March 2013 Scotiabank Awateness Night Dr. Keith Jarvi MD, FRCSC(C) Professor of Surgery, Division of Urology Department of Surgery University of Toronto, Chief of Urology, and Director Murray Koffler Urologic Wellness Centre Mount Sinai Hospital “Prostate Cancer Survivors: What Now?” Survivorship issues in men with prostate cancer Incontinence, Erectile Dysfunction, Fertility, Need for radiation/chemo after surgery/radiation, In Vitro Fertilization and more. CLICK ON THE ARROW TO START THE VIDEO Click here for Video Part 1 Click here for Video Part 2 Introduction by Allan Lappin High Definition Part 1 17:48 minutes […]
March 2013 Scotiabank Awateness Night Rocco Rossi visits PCCN Toronto Prostate Cancer Canada ,President & Chief Executive Officer (CEO) Managing Director of PCCN Rocco Rossi is a Canadian businessman, executive and former political candidate. After graduating from McGill and Princeton University, Rocco’s career included positions with Advanced Material Resources, The Boston Consulting Group, Torstar, Labatt/Interbrew and MGI Software. Rocco’s vast board experience is through his work with the United Way of Greater Toronto, AMR, the Ivey Foundation, the Internet Advertising Bureau of Canada, Toronto’s 2008 Olympic Bid and the Empire Club of Canada. He is also a supporter of Rotary
A study at the Virginia-Maryland Regional College of Veterinary Medicine has identified a chicken-killing virus as a promising treatment for prostate cancer in humans. Read the article.
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease. This is the main conclusion to come out of a study published this week in the Journal of Clinical Oncology, in which David Olmos, Head of the Prostate Cancer and Genitourinary Tumours Clinical Research Unit at the Spanish National Cancer Research Centre (CNIO), has taken part in, along with Elena Castro, a member of the Unit, and British researchers at The Institute of Cancer Research and The Royal Marsden NHS Foundation
Sophisticated new prostate cancer tests are coming to market that might supplement the unreliable P.S.A. test, potentially saving tens of thousands of men each year from unnecessary biopsies, operations and radiation treatments. Read the article.
Laser ablation, cryotherapy, and hemiablative brachytherapy are among the novel approaches that show promise for the focal treatment of localized prostate cancer (PCa), according to studies presented at the 28th annual congress of the European Association of Urology. Most of these treatments are performed under magnetic resonance imaging (MRI) guidance. Read the article.
By R. Morgan Griffin Reviewed By Varnada Karriem-Norwood, MD Have you given up on exercise? A lot of older people do — just one out of four people between the ages of 65 and 74 exercises regularly. Many people assume that they’re too out-of-shape, or sick, or tired, or just plain old to exercise. They’re wrong. Read the article.